Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Moe Tsuda"'
Autor:
Masato Homma, Satoshi Morita, Toshimi Takano, Satoru Shimizu, Hiroko Bando, Naohito Yamamoto, Masakazu Toi, Hiroshi Ishiguro, Norikazu Masuda, Katsumasa Kuroi, Moe Tsuda, Yasuhiro Yanagita, Naoko Toriguchi, Masahiro Ohgami
Publikováno v:
Cancer Medicine
Background The bioavailability of lapatinib is affected by food, even following the 1 hour fast recommended by the package insert. We hypothesized that overnight fasting would minimize food‐drug interactions. Here, we investigated if lapatinib admi
Autor:
Tatsuki R. Kataoka, Masakazu Toi, Mariko Nishie, Tomoharu Sugie, Moe Tsuda, Takeshi Kotake, Kosuke Kawaguch, Eiji Suzuki, Ayane Yamaguchi, Masahiro Hirata, Masakazu Hattori, Fengling Pu
Publikováno v:
Cancer Immunology, Immunotherapy. 70:817-830
Among several mechanisms for the resistance of human epidermal growth factor receptor 2-overexpressing (HER2 +) cancer cells to trastuzumab, little is known regarding the mechanism underlying the resistance to trastuzumab-mediated antibody-dependent
Autor:
Satoshi Morita, Ryuji Uozumi, Fengling Pu, Kosuke Kawaguchi, Eiji Suzuki, Takeshi Kotake, Ayane Yamaguchi, Moe Tsuda, Masahiro Sugimoto, Mariko Nishie, Masakazu Toi
Publikováno v:
Breast Cancer. 26:282-289
It has been reported that the gene expression profile of peripheral blood mononuclear cells (PBMCs) exhibits a unique gene expression signature in several types of cancer. In this study, we aimed to explore the breast cancer patient-specific gene exp
Autor:
Moe Tsuda, Masakazu Toi
Publikováno v:
Translational Cancer Research. 7:S480-S483
Aromatase inhibitors (AIs) are the standard of care for treatment of both early and advanced hormone-sensitive breast cancer in postmenopausal women. Although AIs have been considered to be well-tolerated, only 50 % of patients can complete the full
Autor:
Hidenori Arai, Masakazu Toi, Satoshi Imai, Akiko Hanai, Moe Tsuda, Hiroshi Ishiguro, Ikuko Yano, Takayuki Nakagawa, Takashi Sozu, Tadao Tsuboyama, Yoko Hamabe
Publikováno v:
JNCI Journal of the National Cancer Institute
Background Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting and disabling side effect of taxane anticancer agents. We prospectively evaluated the efficacy of cryotherapy for CIPN prevention. Methods Breast cancer patients treated
Autor:
Hironori Haga, Masashi Inoue, Masahiro Hirata, Isao Kii, Kosuke Kawaguchi, Mariko Nishie, Eiji Suzuki, Masakazu Toi, Fengling Pu, Keiko Iwaisako, Tatsuki R. Kataoka, Moe Tsuda, Masatoshi Hagiwara, Ayane Yamaguchi
Publikováno v:
Cancer Immunology, Immunotherapy. 66:1131-1142
Neuropilin-1 (NRP-1)-expressing macrophages are engaged in antitumor immune functions via various mechanisms. In this study, we investigated the role of NRP-1 on macrophages in antibody-mediated tumoricidal activity. Treatment of macrophages with NRP
Autor:
Hiroko Bando, Toshimi Takano, Noriyuki Masuda, Satoshi Morita, M. Toi, Hiroshi Ishiguro, Satoru Shimizu, Masato Homma, N. Toriguchi, Katsumasa Kuroi, Noboru Yamamoto, Moe Tsuda, Masahiro Ohgami
Publikováno v:
Cancer Research. 77:P2-11
Background: In neoadjuvant dual HER2 blockade, over 30% of patients fail to complete treatment as planned because of lapatinib-induced diarrhea, rash, and hepatotoxicity. Lapatinib bioavailability, which affects both efficacy and toxicity, is influen
Autor:
Kuniaki Saito, Takashi Nojiri, Motofumi Kumazoe, Masakazu Toi, Masashi Sakurai, Yasuko Yamamoto, Tatsuki R. Kataoka, Kosuke Kawaguchi, Moe Tsuda, Eiji Suzuki, Masahiro Hirata, Mariko Nishie
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Scientific Reports
Scientific Reports
Systemic inflammation has been associated with aggressive tumor growth, invasion, and metastasis. Here we performed a comprehensive analysis of 26 kinds of inflammatory cytokine expression patterns among 185 patients with breast cancer and 54 healthy
Autor:
Akira Mitani, Moe Tsuda, Hiroshi Ishiguro, Tadao Tsuboyama, Akiko Hanai, Hidenori Arai, Takashi Sozu
Publikováno v:
Breast Cancer Research and Treatment
Research on patient-reported outcomes indicates that constipation is a common adverse effect of chemotherapy, and the use of 5-hydroxytryptamine (serotonin; 5HT3) receptor antagonists aggravates this condition. As cancer patients take multiple drugs
Autor:
Yoko Hamabe, Akiko Hanai, Ikuko Yano, Satoshi Imai, Masakazu Toi, Tadao Tsuboyama, Moe Tsuda, Hidenori Arai, Takayuki Nakagawa, Takashi Sozu, Hiroshi Ishiguro
Publikováno v:
Annals of Oncology. 29:vii65